CSL Seqirus UK Privacy Notice
Please see the privacy notice below for information about how CSL Seqirus UK processes personal data in connection with its stakeholder engagement activities.
Disclosures and Transparency
Modern Slavery
Each year, the Board approves CSL’s Statement on the Prevention of Human Trafficking, Slavery and Forced Labour. The Statement details the steps the CSL Group is currently undertaking to address and prevent modern slavery. CSL published its first statement in 2016.
Tax Transparency
Seqirus is guided in tax matters by a CSL board-approved tax philosophy which among other things, commits the company to publishing an annual Tax Transparency Report. Our first report was published in 2018.
EFPIA Disclosure Code
At Seqirus, we believe the nature and scope of our cooperation with healthcare professionals and organisations should be clear and transparent to the public. In Europe, we use the principles within the EFPIA Disclosure Code to calculate the Transfers of Value to Healthcare Professionals and Healthcare Organisations and discloses reports for each European country annually.
This publication does not grant a general permission for those accessing the website to undertake additional processing of the healthcare professionals data, such as crossing the data with information published in other companies’ websites.
ABPI Disclosure UK
Disclosure UK is part of a Europe wide industry led initiative to increase transparency between the pharmaceutical industry and the Healthcare professionals and Organisations it works with.
CSL Seqirus UK abide by the ABPI Code of Practice and part of that commitment includes disclosing all relevant transfers of value made to Healthcare Professionals, Other Relevant Decision Makers, and Healthcare organisations which can be accessed via the ABPI central platform https://search.disclosureuk.org.uk/. Our methodological note can be accessed via https://www.abpi.org.uk/reputation/disclosure-uk/methodological-notes-by-company-and-year/.
Relevant transfers of value relating to our engagements with Patient Organisations can be accessed below along with our methodological note regarding these transfers of values.
UK Gender Pay Gap Report
Seqirus is committed to workforce diversity and equity, as detailed in our Code of Responsible Business Practice. In accordance with UK regulations, Seqirus discloses gender pay gap information relating to our UK operations. Our first report covered 2017 and is published annually.
Each year, the Board approves CSL’s Statement on the Prevention of Human Trafficking, Slavery and Forced Labour. The Statement details the steps the CSL Group is currently undertaking to address and prevent modern slavery. CSL published its first statement in 2016.
Tax Transparency
Seqirus is guided in tax matters by a CSL board-approved tax philosophy which among other things, commits the company to publishing an annual Tax Transparency Report. Our first report was published in 2018.
EFPIA Disclosure Code
At Seqirus, we believe the nature and scope of our cooperation with healthcare professionals and organisations should be clear and transparent to the public. In Europe, we use the principles within the EFPIA Disclosure Code to calculate the Transfers of Value to Healthcare Professionals and Healthcare Organisations and discloses reports for each European country annually.
This publication does not grant a general permission for those accessing the website to undertake additional processing of the healthcare professionals data, such as crossing the data with information published in other companies’ websites.
ABPI Disclosure UK
Disclosure UK is part of a Europe wide industry led initiative to increase transparency between the pharmaceutical industry and the Healthcare professionals and Organisations it works with.
CSL Seqirus UK abide by the ABPI Code of Practice and part of that commitment includes disclosing all relevant transfers of value made to Healthcare Professionals, Other Relevant Decision Makers, and Healthcare organisations which can be accessed via the ABPI central platform https://search.disclosureuk.org.uk/. Our methodological note can be accessed via https://www.abpi.org.uk/reputation/disclosure-uk/methodological-notes-by-company-and-year/.
Relevant transfers of value relating to our engagements with Patient Organisations can be accessed below along with our methodological note regarding these transfers of values.
UK Gender Pay Gap Report
Seqirus is committed to workforce diversity and equity, as detailed in our Code of Responsible Business Practice. In accordance with UK regulations, Seqirus discloses gender pay gap information relating to our UK operations. Our first report covered 2017 and is published annually.
CSL Seqirus Disclosure Reports
GBR-CRP-24-0007 June 2024